🕊️ Palliative Care in Advanced Lung Disease Symptom Management · Advance Care Planning · End‑of‑Life Care for Medical Students

1. The Role of Palliative Care in Pulmonary Medicine

Key Concept Palliative care is specialized medical care for people living with serious illness, focused on providing relief from symptoms and stress, and improving quality of life for both patient and family. It is appropriate at any age and at any stage of serious illness and can be provided alongside curative treatment.

• Advanced lung diseases (COPD, ILD, lung cancer, PAH) are characterized by high symptom burden (dyspnea, cough, fatigue, anxiety) and unpredictable disease trajectories.
• Palliative care integration improves quality of life, reduces symptom burden, and may reduce healthcare utilization.
• Palliative care ≠ hospice. Hospice is a specific type of palliative care for patients with life expectancy ≤6 months who are no longer pursuing curative or life‑prolonging therapies.

2. Management of Refractory Dyspnea

Dyspnea is the most common and distressing symptom in advanced lung disease. It often persists despite optimal disease‑specific therapy.

Non‑Pharmacologic Interventions (First‑Line)

• Fan therapy: Cool air directed at the face (trigeminal nerve stimulation) reduces central dyspnea perception. Strong evidence, no side effects.
• Positioning: Upright, leaning forward with arms supported (tripod position) optimizes respiratory mechanics.
• Pursed‑lip breathing: Reduces dynamic hyperinflation in COPD.
• Energy conservation & pacing: Occupational therapy involvement.
• Relaxation techniques, mindfulness, cognitive‑behavioral therapy.
• Supplemental oxygen: Only if hypoxemic (SpO₂ ≤88% at rest or with exertion). Oxygen is not superior to room air for dyspnea relief in non‑hypoxemic patients.

Pharmacologic Management: Opioids for Dyspnea

• Mechanism: Reduce respiratory drive, alter central perception of breathlessness, reduce anxiety.
• Evidence: Low‑dose oral or parenteral opioids reduce refractory dyspnea without significant respiratory depression in opioid‑naïve patients with advanced disease.
• Regimen (Opioid‑Naïve Patient):
  • Oral morphine: Start 2.5‑5 mg PO every 4 hours PRN. If effective and well‑tolerated, convert to scheduled long‑acting morphine (e.g., 10‑15 mg BID).
  • Alternative: Hydromorphone 0.5‑1 mg PO q4h PRN.
  • Monitoring: Sedation, constipation (start bowel regimen), nausea. Respiratory depression is rare with low‑dose, titrated opioids in this population.
• Other agents: Anxiolytics (benzodiazepines) may be added for anxiety‑driven dyspnea but are not first‑line. Nebulized furosemide has limited evidence.

3. Management of Chronic Cough in Advanced Lung Disease

• Chronic cough affects ~70‑90% of patients with advanced COPD, ILD, and lung cancer. Causes significant physical and psychological distress.
• First treat underlying causes: infection, GERD, post‑nasal drip, drug‑induced (ACE inhibitors).

Pharmacologic Options

4. Anxiety, Depression & Existential Distress

• Anxiety and panic are common in advanced lung disease, often intertwined with dyspnea ("dyspnea‑anxiety cycle").
• Depression is underdiagnosed and associated with worse outcomes, reduced adherence, and increased healthcare utilization.

Management Approach

• Non‑pharmacologic: Cognitive‑behavioral therapy (CBT), mindfulness‑based stress reduction, support groups.
• Pharmacologic:
  • SSRIs: Sertraline, citalopram, escitalopram. Safe in most patients. Start low, titrate slowly.
  • Mirtazapine: Useful for depression + insomnia + poor appetite/anorexia. Can cause sedation, weight gain.
  • Benzodiazepines: Short‑term for acute anxiety or panic. Risk of respiratory depression, falls, delirium. Use cautiously in elderly, COPD.

5. Advance Care Planning (ACP) & Goals of Care Discussions

Core Competency ACP is a process of communication between patients, families, and clinicians about future medical care preferences, particularly regarding life‑sustaining treatments.

Key Components

• Identify a healthcare proxy / surrogate decision‑maker.
• Discuss goals and values: What is most important to the patient? What does quality of life mean to them?
• Explore specific treatment preferences: Mechanical ventilation, CPR (code status), artificial nutrition/hydration, dialysis.
• Complete advance directives: Living will, healthcare power of attorney, POLST/MOLST (Physician/Medical Orders for Life‑Sustaining Treatment).

Communication Frameworks

• SPIKES (for breaking bad news): Setting, Perception, Invitation, Knowledge, Empathy, Strategy/Summary.
• Ask‑Tell‑Ask: Assess understanding → provide information → assess response.
• "Hope for the best, prepare for the rest."

6. Hospice Eligibility for Pulmonary Disease

Hospice is a Medicare/Medicaid benefit for patients with life expectancy ≤6 months if the disease runs its usual course, who choose comfort‑focused care over curative/life‑prolonging treatment.

General Hospice Eligibility Criteria (Medicare)

• Patient elects the hospice benefit and forgoes curative/life‑prolonging treatment.
• Certification by two physicians of terminal illness with prognosis ≤6 months.

Pulmonary‑Specific Guidelines (LCD for Hospice)

7. End‑of‑Life Symptom Management: The "Terminal Phase"

In the final hours to days of life, the focus shifts to comfort and dignity.

Common Symptoms at End of Life

Withdrawal of Non‑Beneficial Treatments

• Discontinuing mechanical ventilation (terminal extubation): Pre‑medicate with opioids ± benzodiazepines to prevent dyspnea and distress. Remove ETT, provide humidified air/oxygen via nasal cannula or face mask. Family presence encouraged.
• Discontinuing supplemental oxygen: In a dying patient who is not conscious and not showing signs of respiratory distress, oxygen may not provide comfort and can be discontinued to reduce burdensome interventions. Fan therapy remains effective.
• Deactivating implantable cardioverter‑defibrillators (ICDs): Prevents painful shocks in the dying process. Important to address early.

8. Communication Pearls for Difficult Conversations

• Use "I wish" statements: "I wish the treatments were working better." "I wish I had better news."
• Allow silence: Give space for emotion and processing.
• Respond to emotion with empathy (NURSE): Naming ("I can see this is frustrating"), Understanding ("I can't imagine how hard this is"), Respecting ("You've been so strong"), Supporting ("We will be here with you"), Exploring ("Tell me more about your fears").
• Avoid "There's nothing more we can do." Instead: "There's nothing more we can do to cure the disease, but there is a lot we can do to keep you comfortable and support your family."

9. Quick Reference: Palliative Care in Pulmonary Disease